News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,622 Results
Type
Article (44446)
Company Profile (225)
Press Release (649935)
Multimedia
Podcasts (146)
Webinars (19)
Section
Business (190499)
Career Advice (2862)
Deals (35249)
Drug Delivery (134)
Drug Development (79543)
Employer Resources (169)
FDA (16546)
Job Trends (15625)
News (330413)
Policy (32292)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2759)
Academic (1)
Accelerated approval (31)
Adcomms (33)
Allergies (146)
Alliances (47683)
ALS (179)
Alzheimer's disease (1739)
Antibody-drug conjugate (ADC) (324)
Approvals (16794)
Artificial intelligence (559)
Autoimmune disease (159)
Automation (36)
Bankruptcy (329)
Best Places to Work (12262)
BIOSECURE Act (21)
Biosimilars (197)
Biotechnology (115)
Bladder cancer (161)
Brain cancer (60)
Breast cancer (651)
Cancer (4922)
Cardiovascular disease (431)
Career advice (2407)
Career pathing (40)
CAR-T (290)
CDC (48)
Celiac Disease (2)
Cell therapy (777)
Cervical cancer (35)
Clinical research (68095)
Collaboration (1804)
Company closure (4)
Compensation (1157)
Complete response letters (66)
COVID-19 (2720)
CRISPR (98)
C-suite (870)
Cystic fibrosis (153)
Data (6296)
Decentralized trials (2)
Denatured (41)
Depression (140)
Diabetes (515)
Diagnostics (7002)
Digital health (46)
Diversity (11)
Diversity, equity & inclusion (40)
Drug discovery (254)
Drug pricing (220)
Drug shortages (34)
Duchenne muscular dystrophy (228)
Earnings (79133)
Editorial (64)
Employer branding (21)
Employer resources (152)
Events (115155)
Executive appointments (1025)
FDA (19717)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1503)
Gene editing (210)
Generative AI (47)
Gene therapy (622)
GLP-1 (1053)
Government (4627)
Grass and pollen (7)
Guidances (383)
Healthcare (20132)
HIV (58)
Huntington's disease (45)
IgA nephropathy (86)
Immunology and inflammation (270)
Immuno-oncology (57)
Indications (104)
Infectious disease (2995)
Inflammatory bowel disease (199)
Inflation Reduction Act (14)
Influenza (111)
Intellectual property (250)
Interviews (548)
IPO (16819)
IRA (57)
Job creations (3723)
Job search strategy (1979)
JPM (65)
Kidney cancer (17)
Labor market (77)
Layoffs (578)
Leadership (39)
Legal (7587)
Liver cancer (85)
Longevity (14)
Lung cancer (656)
Lymphoma (376)
Machine learning (44)
Management (64)
Manufacturing (824)
MASH (172)
Medical device (14487)
Medtech (14543)
Mergers & acquisitions (19564)
Metabolic disorders (1348)
Multiple sclerosis (160)
NASH (21)
Neurodegenerative disease (336)
Neuropsychiatric disorders (95)
Neuroscience (3017)
Neurotech (1)
NextGen: Class of 2026 (6951)
Non-profit (4886)
Now hiring (62)
Obesity (651)
Opinion (317)
Ovarian cancer (167)
Pain (216)
Pancreatic cancer (226)
Parkinson's disease (298)
Partnered (32)
Patents (503)
Patient recruitment (491)
Peanut (59)
People (57732)
Pharmaceutical (89)
Pharmacy benefit managers (33)
Phase 1 (21252)
Phase 2 (30044)
Phase 3 (22505)
Pipeline (5192)
Policy (317)
Postmarket research (2310)
Preclinical (8825)
Press Release (62)
Prostate cancer (245)
Psychedelics (51)
Radiopharmaceuticals (295)
Rare diseases (887)
Real estate (5701)
Recruiting (71)
Regulatory (24583)
Reports (34)
Research institute (2565)
Resumes & cover letters (457)
Rett syndrome (27)
RNA editing (17)
RSV (81)
Schizophrenia (156)
Series A (247)
Series B (192)
Service/supplier (11)
Sickle cell disease (104)
Special edition (25)
Spinal muscular atrophy (165)
Sponsored (38)
Startups (3448)
State (2)
Stomach cancer (15)
Supply chain (111)
Tariffs (100)
The Weekly (103)
Vaccines (982)
Venture capital (93)
Weight loss (441)
Women's health (81)
Worklife (21)
Date
Last 7 days (634)
Last 30 days (2214)
Last 365 days (31334)
2026 (2989)
2025 (31804)
2024 (36775)
2023 (41797)
2022 (52921)
2021 (57599)
2020 (56250)
2019 (49488)
2018 (37384)
2017 (33626)
2016 (32398)
2015 (37650)
2014 (28384)
2013 (23061)
2012 (24595)
2011 (25184)
2010 (22424)
Location
Africa (882)
Alabama (91)
Alaska (7)
Arizona (251)
Arkansas (13)
Asia (42464)
Australia (7113)
California (11422)
Canada (3300)
China (1154)
Colorado (485)
Connecticut (494)
Delaware (342)
Europe (94104)
Florida (1695)
Georgia (372)
Hawaii (3)
Idaho (62)
Illinois (892)
India (65)
Indiana (541)
Iowa (22)
Japan (430)
Kansas (124)
Kentucky (42)
Louisiana (26)
Maine (83)
Maryland (1394)
Massachusetts (8387)
Michigan (345)
Minnesota (641)
Mississippi (6)
Missouri (137)
Montana (34)
Nebraska (28)
Nevada (127)
New Hampshire (85)
New Jersey (3082)
New Mexico (31)
New York (3025)
North Carolina (1530)
North Dakota (10)
Northern California (5562)
Ohio (348)
Oklahoma (22)
Oregon (45)
Pennsylvania (2297)
Puerto Rico (23)
Rhode Island (48)
South America (1233)
South Carolina (66)
South Dakota (1)
Southern California (4466)
Tennessee (174)
Texas (1777)
United States (40938)
Utah (349)
Vermont (1)
Virginia (280)
Washington D.C. (83)
Washington State (953)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
694,622 Results for "vicore pharma ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vicore Pharma To Move To The Nasdaq Stockholm Mid Cap Segment
December 19, 2025
·
1 min read
Press Releases
Increase in Number of Shares and Votes in Vicore Pharma
November 28, 2025
·
1 min read
Press Releases
Vicore Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
·
1 min read
Press Releases
Bulletin from the Annual General Meeting of Vicore Pharma Holding AB (publ)
May 7, 2025
·
4 min read
Press Releases
Nomination Committee Appointed for AGM 2026 in Ascelia Pharma AB
December 22, 2025
·
2 min read
Press Releases
Vicore to Present at the Oppenheimer Movers in Rare Disease Summit
December 5, 2025
·
1 min read
Press Releases
Vicore to Present at the DNB Carnegie Nordic Healthcare Conference
November 20, 2025
·
1 min read
Notice of Annual General Meeting of Vicore Pharma Holding AB (publ)
Vicore Pharma Holding The shareholders of Vicore Pharma Holding AB, Reg. No. 556680-3804, with its registered offices in Stockholm, are summoned to the annual general meeting on Tuesday 7 May 2024 at 14.00 in the premises of the law firm Vinge at Smålandsgatan 20, SE-111 46 Stockholm, Sweden.
April 4, 2024
·
32 min read
Press Releases
Vicore to Present at The 2025 Jefferies Global Healthcare Conference in London
November 17, 2025
·
1 min read
Increase of Number of Shares and Votes in Vicore Pharma
Vicore Pharma Holding AB announced that the number of Vicore shares and votes has increased following the exercise of warrants with subsequent delivery of shares to a participant in the incentive program Board LTIP 2023.
May 31, 2024
·
2 min read
1 of 69,463
Next
